Results 201 to 210 of about 243,296 (232)
Some of the next articles are maybe not open access.

VX Percutaneous Studies in Man

1960
Abstract : The effect of percutaneous administration of VX on 103 subjects using 50, 100, 200 mu aerosol particles, single and multiple drops, was studied. VX as neat agent, in doses from 5 to 35 microgram/kg, was applied to the skin of right volar forearm, or hand, or neck.
Jane L. Stubbs, V. M. Sim
openaire   +1 more source

PRELIMINARY GROUP CLASSIFICATION OF EQUATION vt = f ( x,vx ) vxx + g ( x,vx )

Acta Mathematica Scientia, 1997
Abstract Using the method of preliminary group classification introduced by Ibragimov et al[J. Math. Phys. 32, 2988(1991)], we give a classification of equations vt = f(x, vx)vxx + g(x,vx) which admitting an extension by one of the principal Lie algebra of the equation.
openaire   +1 more source

VX-497

Drugs of the Future, 2000
null Sorbera, L.A.   +3 more
openaire   +1 more source

Russian VX

2020
Vladimir Rembovskiy   +11 more
openaire   +1 more source

VX-745. Vertex Pharmaceuticals.

Current opinion in investigational drugs (London, England : 2000), 2002
VX-745, a lead anti-inflammatory candidate, small-molecule inhibitor of mitogen-activated protein kinase (MAPK), is under development by Vertex Pharmaceuticals Inc in association with Kissei Pharmaceutical Co Ltd for the potential treatment of rheumatoid arthritis (RA) [214928].
openaire   +1 more source

VX

2014
R.A. Moyer, F.R. Sidell, H. Salem
openaire   +1 more source

VX

2005
Harry Salem, Frederick R. Sidell
openaire   +1 more source

DESTROYING VX

Chemical & Engineering News Archive, 2004
openaire   +1 more source

Insulin/vx-880

Reactions Weekly, 2022
openaire   +1 more source

VX Aurigae

Astronomische Nachrichten, 1932
openaire   +1 more source

Home - About - Disclaimer - Privacy